- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06254053
Clinical and Radiographic Evaluation of Zirconomer Restorative (Zirconomer)
August 7, 2026 updated by: Tamador Ahmed Ibrahim, Cairo University
Clinical and Radiographic Evaluation of Zirconomer Restorative Material Versus a Glass Ionomer Cement in Restoration of Primary Molars A Randomized Clinical Trial
Is zirconomer restorative material more effective than a glass ionomer cement in restoration of primary molars
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This trial seeks to evaluate the clinical and radiographic performance of two materials zirconomer restorative material and glass ionomer cement to achieve better treatment for primary molars.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Cairo Governorate
-
Cairo, Cairo Governorate, Egypt, 0000
- Cairo University dental hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion criteria:
- Children having carious primary molars(class1) without pulp exposure and normal radiograph.
- Children between age 5 and 7 years.
- Both male and female are included.
Cooperative Children.
Exclusion criteria:
- Patients with systemic diseases.
- Parent refuse to participate.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Zirconomer Restorative material in primary molar
Arm one zirconomer restorative material (intervention)
|
Restorative material
Other Names:
|
|
Active Comparator: Glass Ionomer Cement in primary molar
Arm two Glass Ionomer cement (control)
|
Restorative material
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recurrent CariesColor match
Time Frame: 12 MONTHS
|
Radiographic Visual inspection using Modified United States Public Health Service Ryge criteria USPHS
|
12 MONTHS
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Color match
Time Frame: 12 MONTHS
|
visual inspection using Modified United States Public Health Service Ryge criteria USPHS
|
12 MONTHS
|
|
Marginal Discoloration
Time Frame: 12 MONTHS
|
using visual inspection Modified United States Public Health Service Ryge criteria USPHS
|
12 MONTHS
|
|
Marginal Adaptation
Time Frame: 12 MONTHS
|
using visual inspection Modified United States Public Health Service Ryge criteria USPHS
|
12 MONTHS
|
|
-Anatomic Form
Time Frame: 12 MONTHS
|
using visual inspection Modified United States Public Health Service Ryge criteria USPHS
|
12 MONTHS
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: sherien ez zaldein, professor, Cairo University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Albeshti R, Shahid S. Evaluation of Microleakage in Zirconomer(R): A Zirconia Reinforced Glass Ionomer Cement. Acta Stomatol Croat. 2018 Jun;52(2):97-104. doi: 10.15644/asc52/2/2.
- Arora D, Jain M, Suma Sogi HP, Shahi P, Gupta I, Sandhu M. In vivo evaluation of clinical performance of Cention N and glass ionomer cement in proximal restorations of primary molars. J Indian Soc Pedod Prev Dent. 2022 Jan-Mar;40(1):23-29. doi: 10.4103/jisppd.jisppd_108_21.
- Mushtaq U, Mushtaq F, Thakur D, Rathee K, Poonia N, Khullar S. Comparative Evaluation of Postoperative Sensitivity Following Restoration of Class I Lesions with Different Restorative Materials: An In Vivo Study. J Contemp Dent Pract. 2021 Jun 1;22(6):650-654.
- undefined
- Nanavati K, Katge F, Chimata VK, Pradhan D, Kamble A, Patil D. Comparative Evaluation of Shear Bond Strength of Bioactive Restorative Material, Zirconia Reinforced Glass Ionomer Cement and Conventional Glass Ionomer Cement to the Dentinal Surface of Primary Molars: an in vitro Study. J Dent (Shiraz). 2021 Dec;22(4):260-266. doi: 10.30476/DENTJODS.2021.87115.1230.
- Kukreja R, Singla S, Bhadoria N, Pawar P, Gupta K, Khandelwal D, Dewani N. An In Vitro Study to Compare the Release of Fluoride from Glass Ionomer Cement (Fuji IX) and Zirconomer. Int J Clin Pediatr Dent. 2022 Jan-Feb;15(1):35-37. doi: 10.5005/jp-journals-10005-2141.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2025
Primary Completion (Actual)
April 1, 2026
Study Completion (Actual)
May 1, 2026
Study Registration Dates
First Submitted
January 30, 2024
First Submitted That Met QC Criteria
February 8, 2024
First Posted (Actual)
February 12, 2024
Study Record Updates
Last Update Posted (Actual)
August 12, 2026
Last Update Submitted That Met QC Criteria
August 7, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Evaluation of zirconomer
- cairo university (Other Grant/Funding Number: faculty of pedatric dentistry)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
study protocol and statistical analysis
IPD Sharing Time Frame
after one year
IPD Sharing Access Criteria
with other investigator including who will work with systematic review ,will provide the clinical study report with the documents above
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.